Adds analyst comment. GeneDX (NASDAQ:WGS) fell 4% after a short report from Grizzly Research on the genetic testing company. Grizzly Research disclosed that it's short shares of GeneDX (NASDAQ:WGS).

See today’s best-performing stocks on TipRanks >> Natera (NTRA) BTIG analyst Mark Massaro maintained a Buy ... The word on The Street in general, suggests a Strong Buy analyst consensus rating ...

BTIG analyst Mark Massaro reiterated a Buy rating on Adaptive Biotechnologies (NASDAQ:ADPT) Corp on Tuesday, setting a price target of $74, which is approximately 102.19% above the... BTIG analyst ...

The meet record for St. John’s Prep unseated the prior mark set back in 2019 ... Angell and Sullivan teamed up with Lincoln Massaro for the victory (19.52 meters), setting a meet record in ...

BTIG analyst Mark Massaro notes that earlier today, a short report was published on GeneDx (WGS), which alleges wholesale reimbursement fraud at the company. Shares were down about 4%, and BTIG ...

Tuesday afternoon, the City Council appointed the developer Lisa Massaro and Eryn Ebach, a land-use planner, to Napa's land use advisory body. You can reach Riley Palmer at 707-256-2212 or riley ...

Additionally, Mr. Massaro will be joined by Gabriel Bien-Willner, MD, PhD, Chief Medical Officer of Palmetto GBA and Medical Director of the MolDX (Molecular Diagnostic Services) Program and Brian ...

President Donald Trump focused his ire and retaliation on one person in the very first minutes of his presidency, even before ...

Defense Secretary Pete Hegseth is pulling the security protections and clearance of retired Joint Chiefs Chairman Gen. Mark ...